3-Deazaneplanocin A - an overview | ScienceDirect Topics
Targeting Enhancer of Zeste Homolog 2 as a promising strategy for cancer treatment
DZNep inhibits histone methylation, reduces cellular Ezh2, and alters... | Download Scientific Diagram
![DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p/SOCS7 pathway [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2021/11374/1/fig-1-full.png "DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p/SOCS7 pathway [PeerJ]")
DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p/SOCS7 pathway [PeerJ]
Histone Methylation Inhibitor DZNep Ameliorated the Renal Ischemia-Reperfusion Injury via Inhibiting TIM-1 Mediated T Cell Activation | Medicine - Frontiers
3-Deazaneplanocin A hydrochloride (DZNep hydrochloride) | EZH2 Inhibitor | MedChemExpress
Epigenetic regulation of endothelial‐cell‐mediated vascular repair - Fraineau - 2015 - The FEBS Journal - Wiley Online Library
Epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A inhibits the growth of cholangiocarcinoma cells
Cancers | Free Full-Text | Co-Treatment with the Epigenetic Drug, 3-Deazaneplanocin A (DZNep) and Cisplatin after DZNep Priming Enhances the Response to Platinum-Based Therapy in Chondrosarcomas | HTML
Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis
3-Deazaneplanocin A hydrochloride (DZNep hydrochloride) | EZH2 Inhibitor | MedChemExpress
The Effect of EZH2 Inhibition through DZNep on Epithelial–Mesenchymal Transition Mechanism | Cellular Reprogramming
Finding an easy way to harmonize: a review of advances in clinical research and combination strategies of EZH2 inhibitors | Clinical Epigenetics | Full Text
Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells | Oncogenesis
EZH2-inhibitor DZNep enhances apoptosis of renal tubular epithelial cells in presence and absence of cisplatin | Cell Division | Full Text
Cureus | Advances in Epigenetic Cancer Therapeutics
3-Deazaneplanocin A (DZNep), an Inhibitor of S-Adenosylmethionine-dependent Methyltransferase, Promotes Erythroid Differentiation - ScienceDirect
DZNep inhibits H3K27me3 deposition and delays retinal degeneration in the rd1 mice | Cell Death & Disease
3-Deazaneplanocin A (DZNep), an Inhibitor of S-Adenosylmethionine-dependent Methyltransferase, Promotes Erythroid Differentiation* - Journal of Biological Chemistry
The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML - ScienceDirect
3-Deazaneplanocin A (DZNep), an Inhibitor of the Histone Methyltransferase EZH2, Induces Apoptosis and Reduces Cell Migration in Chondrosarcoma Cells
Acquired resistance to DZNep-mediated apoptosis is associated with copy number gains of AHCY in a B-cell lymphoma model | BMC Cancer | Full Text
![DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p/SOCS7 pathway [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2021/11374/1/fig-5-full.png "DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p/SOCS7 pathway [PeerJ]")
DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p/SOCS7 pathway [PeerJ]
3-Deazaneplanocin A (DZNep), an Inhibitor of the Histone Methyltransferase EZH2, Induces Apoptosis and Reduces Cell Migration in Chondrosarcoma Cells
![DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p/SOCS7 pathway [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2021/11374/1/fig-2-full.png "DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p/SOCS7 pathway [PeerJ]")
DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p/SOCS7 pathway [PeerJ]
